Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will ...

The company received USFDA approval for nonsteroidal anti-inflammatory drug, which will be produced at Ahmedabad facility.

Biocon and Zydus Lifesciences are in the spotlight with fresh regulatory approvals fueling bullish analyst sentiment and renewed retail interest. Biocon shares rose 2% on Wednesday after its ...

Stocks like Tech Mahindra, Angel One, L&T Technology Services, Le Travenues Technology, Maruti Suzuki India, State Bank of ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA) at Zydus' formulations manufacturing facility at Matoda in Gujarat for the Prior Approval Supplement (PAS) of ...

The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...

Stocks including HDFC Life Insurance, ICICI Lombard GIC, Bajaj Finserv, HDB Financial, Ashok Leyland, Zydus Lifesciences, ...

After identifying the top-100 large cap stocks, the stocks ranked 101st to 250th by market cap qualify as mid-cap stocks.

ETHealthworld.com brings latest zydus lifesciences news, views and updates from all top sources for the Indian Health industry.

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration ...

The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) ...